文献速递自身免疫性与大疱性皮肤病

氟达拉滨对隐性营养不良性大疱性表皮松解症是否有益?

Does fludarabine have a beneficial effect in recessive dystrophic epidermolysis bullosa?
PubMed 文献 · Br J Dermatol · 2021-01-01

本文解读Vanden Oever等发表于Br J Dermatol的研究,探讨化疗药物氟达拉滨对隐性营养不良性大疱性表皮松解症(RDEB)细胞中VII型胶原(C7)沉积的影响。研究发现氟达拉滨可影响RDEB受累细胞中C7的产生,并描述了相关机制,但强调需区分造血干细胞移植后C7增加来源于植入细胞还是患者自身细胞受药物刺激,且药物可能沉积无功能C7而有潜在危害。

要点

  • 氟达拉滨可影响RDEB受累细胞中C7的产生,机制多样。
  • 需明确造血干细胞移植后C7沉积增加源于植入细胞还是药物刺激自身细胞。
  • 氟达拉滨通常毒性过大,但低毒类似物可能具有临床获益潜力。

核心结论

  • 氟达拉滨对RDEB细胞中C7沉积有影响,但毒性限制其直接应用,低毒类似物值得探索。

研究设计与样本

  • 基于Vanden Oever等发表于Br J Dermatol 2021;185:380-390的研究,作者位于美国明尼阿波利斯,探索化疗药物对C7沉积的影响。

主要发现

  • 氟达拉滨影响RDEB受累细胞中C7的产生,并涉及多种机制。
  • 需确定造血干细胞移植后C7沉积增加中植入细胞与药物刺激患者自身细胞各自的贡献。
  • 药物可能引起无功能C7沉积,从而可能有害。

临床怎么用

  • 氟达拉滨因毒性通常不适用于RDEB患者,但可考虑开发低毒类似物以促进C7沉积并产生临床获益。

局限性

  • 尚需明确移植后C7沉积增加的来源归属,且药物可能沉积无功能C7带来风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Linked Article: Vanden Oever et al. Br J Dermatol 2021; 185:380-390. Recessive dystrophic epidermolysis bullosa (RDEB) is a rare genetic disorder. Patients with RDEB experience severe painful blistering and skin fragility due to separation of two layers of the skin: the dermis and epidermis. This occurs because type VII collagen (C7) is deficient or absent in the skin. C7 is a major component responsible for tethering the epidermis to the dermis. The skin heals with disfiguring scarring, and patients are at risk of secondary infection and an aggressive form of squamous carcinoma, a type of skin cancer. There is currently no cure but there are encouraging results from some experimental treatments. One treatment is haematopoietic stem cell transplantion, where the engrafted cells appear to increase the amount of C7 (a process called deposition) over the long-term. Unfortunately, this treatment requires long term immunosuppression and this is particularly risky in patients with RDEB, who are prone to infections. The authors, based in Minneapolis, USA, explored whether any of the drugs used in chemotherapy treatment used before transplant might have an effect on C7 deposition. They found that fludarabine influences the production of C7 in affected cells in RDEB. They describe various mechanisms for this effect. They stress the need to determine how much the increased C7 deposition following haematopoietic stem cell transplantation is because of the engrafted cells, and how much is from the patient's own cells stimulated by drugs such as fludarabine. They caution that drugs may cause deposition of non-functional C7, which could be harmful. Unfortunately, fludarabine is generally too toxic to use in patients with RDEB, but there is the possibility of less toxic analogues that could have the same desirable effect on C7 deposition and have clinical benefit.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Does fludarabine have a beneficial effect in recessive dystrophic epidermolysis bullosa? Br J Dermatol. 2021. PMID: 34396502. doi:10.1111/bjd.20528

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。